Abergas, Orlyn Mae N.

HRN: 25-47-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2024
CEFUROXIME 750MG (VIAL)
07/14/2024
07/15/2024
IV
750mg
Q8
Postpartum Curettage Followed By Evacuation Of Hematoma
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines